ORIGINAL ARTICLE. Neuronal Differentiation of Human Adipose Tissue Derived Stem Cells for Peripheral Nerve Regeneration In Vivo

Size: px
Start display at page:

Download "ORIGINAL ARTICLE. Neuronal Differentiation of Human Adipose Tissue Derived Stem Cells for Peripheral Nerve Regeneration In Vivo"

Transcription

1 ORIGINAL ARTICLE Neuronal Differentiation of Human Adipose Tissue Derived Stem Cells for Peripheral Nerve Regeneration In Vivo Thomas Scholz, MD; Andrew Sumarto, BS; Alisa Krichevsky, BS; Gregory R. D. Evans, MD Objective: To evaluate the ability of a tissue-engineered nerve construct composed of a nerve guidance channel and neurally differentiated human adipose tissue derived stem cells (hascs) to enhance peripheral nerve regeneration in a rat sciatic nerve model. Design: A 13-mm sciatic nerve gap was bridged with silastic conduits in 64 athymic nude rats, and differentiated hascs were implanted into the nerve gap. The effect of repetitive renewal of differentiation medium on days 14 and 28 was further tested. Adequate negative controls and isograft controls were used. Setting: Academic research. Patients: The hascs were isolated from human adipose tissue of patients undergoing liposuction procedures. Main Outcome Measures: Direct measurements of nerve function included sciatic functional index score, extensor postural thrust, and sensory evaluation. Indirect measurements included gastrocnemius and soleus muscle atrophy. Histomorphometric evaluation included the number and diameter of axons and fibers, nerve fiber density, myelin thickness, g-ratio (axon diameter total fiber diameter ratio), and myelin thickness axon diameter ratio. Results: The use of hascs demonstrated significantly improved functional recovery as measured by the sciatic functional index, extensor postural thrust, sensory evaluation, and gastrocnemius and soleus muscle weight after 14 days and 1, 2, 3, and 4 months. Groups with their medium renewed also demonstrated further enhanced functional recovery compared with their counterparts that did not have their medium renewed. Conclusion: This tissue-engineered nerve construct using hascs was able to improve functional recovery during the first 4 months, comparable with nerve isografts. Arch Surg. 211;146(6): Author Affiliations: Aesthetic and Plastic Surgery Institute, University of California, Irvine, Orange. NERVE LESIONS IN THE PEripheral nervous system are common injuries that affect 2.8% of trauma patients and often result in permanent disability. 1,2 If primary repair of nerve lesions cannot be achieved, the gold standard is the autologous nerve graft. However, this treatment has drawbacks of suboptimal functional recovery rates, limited graft tissue supply, loss of function at the donor site, and donor site morbidity. 3,4 A promising alternative to direct suturing or interposing of an autograft is a tissue-engineered nerve construct that bridges the nerve gap and facilitates the complex interplay between cells, growth factors, and extracellular matrix required for regeneration. Studies have demonstrated that embryonic stem cells and adult neural stem cells isolated from the brain and spinal cord could differentiate into neurons after implantation into an injured nerve, but ethical and logistical concerns have hindered their therapeutic use until now. 4 Some recent studies have described mesenchymal bone marrow derived stem cells (BMSCs) that exhibited the capacity to differentiate into many mesodermal cell types, including neural cell lineages. 5-1 Although these are more plentiful and more accessible than neural progenitor cells, bone marrow aspiration incurs donor site morbidity and often yields limited numbers of cells. 11 Similar to BMSCs, adult human adipose tissue derived stromal cells (hascs) have also been differentiated into various mesodermal cell types but are advantageous in that they are more accessible, have lower donor site morbidity, and are more plentiful. 11,12 Previously, we demon- ARCH SURG/ VOL 146 (NO. 6), JUNE

2 strated that hascs could differentiate into neuronlike cells in vitro using defined culture conditions on a time scale useful for in vivo nerve regeneration. 13 The aim of this study is to evaluate the functionality of a tissue-engineered peripheral nerve construct composed of a nerve guidance channel and differentiated hascs in a rat sciatic nerve model. We hypothesize that these hascs will help bridge a critical size peripheral defect and promote functional nerve regeneration by differentiating into neural cells. METHODS CELL CULTURE After approval from the human subject protection committee, human adipose tissue was acquired from patients undergoing liposuction procedures. The hascs were isolated and expanded from the tissue as previously described and were maintained in culture medium (high-glucose Dulbecco s modified Eagle medium [DMEM]; Cambrex, Walkersville, Maryland) supplemented with 1% fetal bovine serum, 1-IU/mL penicillin, 1-mg/mL streptomycin, and.25-mg/ml amphotericin B (Mediatech, Herndon, Virginia) at 37 C and 5% carbon dioxide. 13 Once 7% confluent, the medium was switched to control medium (high-glucose DMEM was changed to lowglucose DMEM) 3 days prior to carrying out the differentiation protocol. The subconfluent cultures of experimental hascs were washed with phosphate-buffered saline and standardized for cell number. These cells were placed in neuronal induction medium (DE-1 medium), a modification of previously published protocols, which consisted of high-glucose DMEM supplemented with 1% fetal bovine serum,.5mm isobutylmethylxanthine, 1µM dexamethasone (Sigma-Aldrich, St Louis, Missouri), 1µM insulin (Invitrogen, Carlsbad, California), 2µM indomethacin (Sigma-Aldrich), 1% antibiotic/antimycotic solution, 1% nonessential amino acid, 1% N-(2-hydroxyethyl) piperazine-n -(2-ethanesulfonic acid), and 1% L-glutamine. 5 GRAFTING PROCEDURE Sixty-four athymic nude female rats (rnu/rnu rats; Harlan Laboratories, Indianapolis, Indiana) were used to avoid immunologic response to implanted hascs. The animals were anesthetized (with ketamine hydrochloride, xylazine hydrochloride, and atropine sulfate intraperitoneally). A 3-cm skin incision was made, and the underlying gluteus muscle was dissected in a muscle-sparing technique. Once the sciatic nerve was exposed, a 13-mm nerve gap was created. served as a positive control consisting of 1 rats that were treated with 13-mm isografts harvested from the hindlegs of 5 donor animals. Groups 2 through 5 received silastic conduits that were 15 mm in length, with a wall thickness of.38 mm and an inner diameter of 1.25 mm (Pharmaseal, Irwingdale, California). Nerve ends were sutured in place such that they were 1 mm inside the conduit, resulting in a 13-mm nerve gap. The lumens of these conduits were filled with 1 5 hascs suspended in 36 µl of culture medium. was a negative control and consisted of 2 rats that received nondifferentiated hascs in culture medium. consisted of 2 rats that received differentiated hascs with DE-1 medium. Groups 3 and 5 consisted of 12 rats each and received the same treatments as groups 2 and 4, respectively, except their medium was renewed 14 and 28 days after implantation of the nerve construct. To renew the medium, animals were anesthetized and the surgical site was reopened. The fluid within the nerve construct was aspirated with a 1-mL tuberculin syringe, and new culture medium was administered with a 27-gauge needle. All experiments were carried out in accordance with the Institutional Animal Care and Use Committee at the University of California, Irvine, and were consistent with federal guidelines. FUNCTIONAL ASSESSMENT OF REINNERVATION Functional analyses prior to and 1, 2, 3, and 4 months after surgery were carried out. Animals were trained and tested in a walkway (length, 95 cm; width, 12 cm) as previously described. 14 Using 3 to 6 footprints per animal/time point/group, the sciatic functional index (SFI) score was calculated. The extensor postural thrust (EPT) measures the amount of force that a rat can exert onto a digital scale as it extends its hind limb and is an indication of the performance of the soleus and gastrocnemius muscles. The thrusts from the uninjured limb and the injured limb were determined, and the percentage of motor deficit was calculated as previously described. 14 Sensory evaluation was achieved by testing the withdrawal response mediated by myelinated A fibers in response to mechanical stimulation on the plantar skin. A withdrawal reflex of less than 1 second in response to pinprick was recorded as a positive result. At the same time points, 4 animals in groups 2 through 5 and 2 animals in group 1 were harvested to evaluate the wet weights of the gastrocnemius and soleus muscles. Because these muscles atrophy without innervations by the sciatic nerve, the ratios of harvested wet muscle weights of the injured leg to those of the uninjured leg indicated the degree of muscle atrophy. 14 All animals were functionally tested (SFI, EPT, and sensory evaluation) during baseline measurements (n=2), but owing to harvest at 7, 14, and 21 days and 2 months, n=12 for each group for functional testing at 1 month, n=8 at 2 months, and n=4 at 3 and 4 months. For end points regarding harvested tissue (muscle weights and histomorphometry), n=4 for all times consistently. MORPHOLOGICAL AND HISTOMORPHOLOGICAL ANALYSIS At each time, rats were killed with carbon dioxide and nerve tissue was harvested for histological assessment as previously described. 15 After isolation, the nerves were fixed in 4% glutaraldehyde (Fisher Chemicals, Fairlawn, New Jersey), embedded in epoxy resin, cut, and stained with toluidine blue. An oil microscope was used to view cross-sections of the nerve 2 mm distal to the injury site by bright field optics. A chargedcoupled device camera was used to create digital images of the nerve cross-sections. At a magnification of 5, 3 nonoverlapping fields for each nerve segment were analyzed using computer image analysis software to measure axon number, nerve fiber density, axon diameter, fiber diameter, connective proliferation index, and number of small fibers (diameter 6 µm). Using these parameters, the myelin thickness, g-ratio (axon diameter total fiber diameter ratio), and myelin thickness axon fiber diameter ratio were calculated. STATISTICAL ANALYSIS Differences between groups were statistically analyzed using 1-way analysis of variance for gastrocnemius and soleus atrophy because a statistically normal distribution is assumed. In contrast, the SFI, EPT, and sensory evaluations required a nonparametric test, so they were tested using a 2-tailed rank sum test (Mann- Whitney). P.5 was considered statistically significant. ARCH SURG/ VOL 146 (NO. 6), JUNE

3 , mo SFI Score, % 2 7 EPT, % , mo Figure 1. Sciatic functional index (SFI). indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 3, hascs that were noninduced and had their medium (DMEM) renewed; group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed. The tissue-engineered nerve construct with differentiated hacss and renewal of DE-1 medium at days 14 and 28 results in functional outcomes comparable with those of isograft controls during the first 4 months after implantation over a nerve gap of 13 mm. Error bars indicate SD. *P.5. Figure 2. Extensor postural thrust (EPT). indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 3, hascs that were noninduced and had their medium (DMEM) renewed; group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed. The renewal of DE-1 medium within the nerve gap demonstrates less functional motor deficit at 4 months. The effect of differentiated hascs with regard to functional outcome compared with nondifferentiated control groups becomes more obvious over the course of regeneration. Error bars indicate SD. *P.5. RESULTS SCIATIC FUNCTIONAL INDEX At 1 month, all groups had a significant decline in SFI score, which is indicative of lack of function. At 3 months, groups 1 and 5 showed much higher SFI scores than the other groups. The disparity between hascs in DMEM and DE-1 medium was even more apparent 4 months after surgery, with groups 1 and 5 having SFI scores significantly different from those of groups 2, 3, and4(p.5). had the best SFI scores at 4 months (mean [SD], 3.4 [1.9]), but they were not statistically different from the SFI scores of group 5 (mean [SD], 35.1 [12.3]). Also, groups 3 and 5, which had their medium renewed, showed better improvements in SFI score than groups 2 and 4, respectively (Figure 1). EXTENSOR POSTURAL THRUST Similar to the SFI scores, all groups demonstrated motor deficit during the first 2 months. However, 3 months after surgery, groups 1, 4, and 5 showed decreases in motor deficit compared with negative controls. Groups 2 and 3 showed minimal improvement even after 4 months. Groups 1, 4, and 5 were significantly different from groups 2and3(P.5). Groups 1 and 4 had similar improvements in motor deficit to about 38%, while the experimental group 5 showed the lowest motor deficit (mean [SD] EPT value, 29.5 [7.812]). The groups with renewed medium had significantly better EPT values than corresponding groups that did not have their medium renewed (Figure 2). GASTROCNEMIUS AND SOLEUS MUSCLE WEIGHT The ratio of wet weights of the gastrocnemius and soleus muscles of the injured leg to those of the uninjured leg is indicative of muscle atrophy, an indirect parameter for nerve regeneration. In all groups, muscle weights increased with reinnervation. In reference to the gastrocnemius muscle wet weights, group 5 had the highest ratio after 4 months (mean [SD], 77 [6]). This value was significantly greater than those of all other groups at every time (P.5) (Figure 3). The soleus muscles were not significantly different between any of the groups (Figure 4). Renewing the medium had no significant effect in both muscles. SENSORY EVALUATION After 1 month, no animal showed a positive withdrawal from mechanical stimulation. At 2 months, where no appreciable improvements in SFI score and EPT were recorded, a positive sensation was found in groups 1 and 5. After 3 months, all groups demonstrated a positive result. Finally, at 4 months, group 1 demonstrated the greatest sensory improvement (Figure 5). HISTOLOGICAL EVALUATION AND HISTOMORPHOMETRY The histomorphometry of groups 1, 2, 4, and 5 are demonstrated. The number of axons increased within each group but without significant differences (Figure 6). However, the renewal of DE-1 medium after 14 and 28 days resulted in a statistically significant increase in axons from 1 to 2 months and from 2 to 4 months, unlike in group 4, where DE-1 medium was not renewed. The num- ARCH SURG/ VOL 146 (NO. 6), JUNE

4 Gastrocnemius Muscle Atrophy, % , d Figure 3. Gastrocnemius muscle atrophy. indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 3, hascs that were noninduced and had their medium (DMEM) renewed; group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed. As a response to reinnervation, the gastrocnemius muscle wet weight increases over time in all groups. The administration of DE-1 medium resulted in higher muscle mass after 4 months. Error bars indicate SD. *P.5. Soleus Muscle Atrophy, % , d Figure 4. Soleus muscle atrophy. indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 3, hascs that were noninduced and had their medium (DMEM) renewed; group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed. Consistent with the gastrocnemius muscle, the soleus muscle mass is increased by administration of DE-1 medium into the nerve gap. However, these results do not show a statistically significant difference. Error bars indicate SD. Figure 5. Sensory evaluation. indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 3, hascs that were noninduced and had their medium (DMEM) renewed; group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed. Isograft controls demonstrated the best recovery of innervation during the observation period. A positive response was obtained in less than 35% within the groups that received differentiated hascs suspended in DE-1 medium. However, these results were better than the results in groups without DE-1 medium at 4 months. Sensory Evaluation, % , mo ber of small fibers (diameter 6 µm) demonstrated a distribution very similar to the number of axons (Figure 7). Early, at days 7 and 14, we saw significantly fewer small nerve fibers than axons, which indicates that these axons are instead associated with larger fibers. Because small nerve fibers (diameter 6 µm) are considered to be re- ARCH SURG/ VOL 146 (NO. 6), JUNE

5 15 Axons, No./mm Figure 6. Axon number. indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed (group 3, with hascs that were noninduced and had their medium [DMEM] renewed, is not shown). The axon number increased in all groups during the experiment. Isograft controls and the group that received hascs with renewal of DE-1 medium had significantly more axons 2 mm distal to the nerve injury at 4 months. Error bars indicate SD. *P.5. All other results did not show a statistically significant difference. 15 Fibers, No./mm Figure 7. Number of small fibers ( 6 µm). indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed (group 3, with hascs that were noninduced and had their medium [DMEM] renewed, is not shown). The number of small nerve fibers increases over time; however, the undifferentiated hascs have significantly fewer fibers than the differentiated hascs or the isograft controls at 4 months. Error bars indicate SD. *P.5. There are no significant differences between group 1 and group 4 or 5. generating fibers during nerve regeneration, the large fibers might be original nerve fibers that have not been removed by macrophages. The nerve fiber density also correlated well with the previous 2 parameters (Figure 8). Although not significantly different, group 5 had the most axons, most small nerve fibers, and greatest nerve fiber density after 2 and 4 months. In all 3 parameters, the number of axons and fiber density started low and steadily grew. Fiber diameter was larger than 6 µm at days 7 and 14. On day 28, fiber diameter was highly variable. Most fibers were thinner than 6 µm at 2 months but then regained size by 4 months (Figure 9). At 4 months, the fiber diameters of groups 4 and 5 were significantly wider than those of groups 1 and 2. The axon diameter (Figure 1) and myelin thickness (Figure 11) demonstrated patterns comparable to the fiber diameter. Both axons and myelin were thicker at the early times, became significantly thinner at 2 months, and regained thickness at 4 months. The myelin thickness of group 5 was greater than that of the other groups at 4 months. The myelin thickness axon diameter ratio (Figure 12) and g-ratio (Figure 13) did not show any statistically significant differences between any of the groups. COMMENT This study demonstrates an improvement of the sciatic peripheral nerve regeneration over a critical size defect by means of hascs in DE-1 medium within silicone tubing. Silicone tubing was used as a nerve guidance channel instead of a bioactive material to minimize variables ARCH SURG/ VOL 146 (NO. 6), JUNE

6 .6.5 Nerve Fiber Density Figure 8. Nerve fiber density. indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed (group 3, with hascs that were noninduced and had their medium [DMEM] renewed, is not shown). The nerve fiber density of the undifferentiated hascs increased later than those in all other groups that already demonstrated a significant increase in the fiber density after 2 months. Error bars indicate SD. *P.5. Differentiated hascs and the isograft control group are not significantly different at any of the times. 1 Fiber Diameter, µm 5 Figure 9. Fiber diameter. indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed (group 3, with hascs that were noninduced and had their medium [DMEM] renewed, is not shown). The fiber diameter was greater than 6 µm at the early regeneration phase (days 7 and 14), showed a high variability and high standard deviation at day 28, decreased at 2 months, and increased again at 4 months. The changes from 2 to 4 months demonstrate the increase in remyelination of regenerating nerve axons and are best seen in the experimental groups that received differentiated hascs. Error bars indicate SD. *P.5. other than the use of hascs in differentiation medium for our in vivo results. Disadvantages of using synthetic materials such as silicone were never observed within the 4-month observation period. 4 Contrary to our hypothesis, no hascs were found to have differentiated histologically. Furthermore, no formation of synapticlike connections between hascs and the growth cone were observed. It is important to note that improved regeneration is evident in the experimental groups receiving hascs and differentiation medium (groups 4 and 5). The histomorphological analysis demonstrates that fibers have large diameters and thick myelin sheaths at earlier times. These large fibers are low in number and are likely to be nerve fibers of the sciatic nerve stump that have not been removed by macrophages. At months 2 and 4, the histological picture becomes dominated by small fibers. These small regenerating nerve fibers are responsible for the nerve fiber density at these times. During our observation period, nerves began to reach histomorphological parameter levels typical of normal sciatic nerves. Normal rat sciatic nerves approximately have a mean (SD) of 7115 (413) fibers, a mean myelinated fiber diameter of 6.5 µm, and a nerve fiber density of fibers/mm These histological improvements of regenerated axons correlate well with the overall functional improvement of the sciatic nerve. The end-organ functional recovery of the regenerated nerve is the clinically relevant outcome. The functional assessment with the SFI has been extensively used and correlates very well with overall functional recov- ARCH SURG/ VOL 146 (NO. 6), JUNE

7 1 8 Axon Diameter, µm Figure 1. Axon diameter. indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed (group 3, with hascs that were noninduced and had their medium [DMEM] renewed, is not shown). The axon diameter showed results very similar to the distribution of the nerve fiber density, indicating the 2 different populations of nerve fibers in the early and late phases of the regeneration process. The control group with undifferentiated hascs demonstrated significantly smaller diameters at 4 months compared with the groups with differentiated hascs. Differentiated hascs increased significantly from 2 to 4 months in the renewal group. Error bars indicate SD. *P.5. Myelin Thickness, µm Figure 11. Myelin thickness. indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed (group 3, with hascs that were noninduced and had their medium [DMEM] renewed, is not shown). The direct measurement of the myelin thickness revealed significantly higher results for the differentiated hascs after 4 months compared with undifferentiated hascs (*P.5) and higher results compared with isograft controls (not statistically significant). The results match the distribution of the fiber and axon diameters. Error bars indicate SD. ery. 14 Although no major improvements of the SFI score were found after 2 months, the use of induced hascs in differentiation medium that was renewed actually rivaled the SFI score of the isograft treatment after 4 months. Nie et al 17 designed a tissue-engineered nerve filled with differentiated ectomesenchymal stem cells in collagen within a 1-mm nerve gap and achieved SFI results that were not statistically different from those of an autograft treatment after 4 months. However, after 4 months, their values stayed above an index of 4 and were inferior to autografts. In 27, Chen et al 18 used BMSCs in silicone tubes to treat a 15-mm gap and also obtained comparable SFI results 1 weeks after surgery, but they did not perform autograft controls. Their experimental values also stayed above an index of 4. These studies and others performed SFI measurements without a baseline value before surgery, which limits the information gained from SFI measurements. 14,15 Because SFI is a dynamic parameter, we believe it should be interpreted over time in regard to changes before and after surgery. Our study revealed marked improvements of SFI scores after 3 and 4 months. Importantly, group 5, the experimental group that had their medium renewed, had a better SFI score on average than the autografts after 4 months. Although the SFI is the current standard for measuring functional recovery, the variability in SFI measurements requires an alternative test to examine the motor recovery. The results of the EPT coincide with the results of the SFI, as there were considerable improvements after 3 and 4 months. In contrast to the SFI, the EPT showed that group 4 actually achieved functional recovery similar to that of the isograft. exceeded the func- ARCH SURG/ VOL 146 (NO. 6), JUNE

8 Myelin Thickness Axon Diameter Ratio Figure 12. Myelin thickness axon diameter ratio. indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed (group 3, with hascs that were noninduced and had their medium [DMEM] renewed, is not shown). This indirect parameter of nerve regeneration showed higher standard deviations than the direct parameters. Differentiated hascs demonstrated a significantly smaller ratio at day 7 but a significantly higher ratio at 4 months compared with the undifferentiated hascs (*P.5). Error bars indicate SD. Axon Diameter Total Fiber Diameter Ratio Figure 13. Axon diameter total fiber diameter ratio (g-ratio). indicates isograft controls from donor animals; group 2, human adipose tissue derived stem cells (hascs) that were noninduced and maintained with Dulbecco s modified Eagle medium (DMEM); group 4, hascs that were induced and placed in differentiation medium (DE-1 medium); and group 5, hascs that were induced and had their differentiation medium (DE-1 medium) renewed (group 3, with hascs that were noninduced and had their medium [DMEM] renewed, is not shown). The g-ratio did not produce any statistically significant differences between groups and within any of the groups. Error bars indicate SD. Note the high standard deviations for this indirect and calculated parameter. tional recovery of both group 4 and the isograft. The SFI and EPT indicate that functional recovery was incomplete after 4 months. Nevertheless, the use of hascs appears to be advantageous. In 24, Kim et al 19 used acellular nerve allograft and attained significant improvements, but these improvements were only 16% to 26% of that of normal nerves after 6 months. In contrast, group 5 shows a much better recovery in EPT after only 4 months. It appears that our cellularized tissue constructs could be a more promising approach than their acellular counterparts. The gastrocnemius muscle regains mass directly proportional to the extent of reinnervation. Although our experimental group reached a significantly improved outcome, it was still lower than native, normal innervated muscle. This outcome suggests that regeneration is not yet complete. Additionally, these indicate that nerve regeneration and regain of function most likely take longer than 4 months, and a longer observation period is needed to determine whether full recovery is ever achieved. Nevertheless, the muscle weights of the experimental groups rivaled those of the isograft. Importantly, group 5 actually had muscle weights significantly larger than those of the isograft. This result contrasts with the SFI outcomes, as group 5 had a slightly lower average SFI score than the isograft group. The positive result in the gastrocnemius muscle weights indicates a lower degree of muscle atrophy due to greater reinnervation. In contrast to a study by Clavijo-Alvarez et al 2 in 27, the use of hascs in silicone tubing appears to be superior to acellular solutions. Overall, group 5 demonstrated the greatest motor recovery, as it had results either comparable with or superior to those of the isografts in every parameter. Because our hascs do not differentiate into neurons, these histomorphological and functional outcomes suggest that hascs may help improve motor nerve regeneration through the production of neurotrophins such as neural growth factor, which is primarily responsible for the regeneration of motor neurons. 4 ARCH SURG/ VOL 146 (NO. 6), JUNE

9 The sensory evaluation demonstrates a faster recovery of sensory neurons in the experimental group compared with controls. The results were comparable with those of Kim et al 19 in 24; however, in their study, animals with 1-mm sciatic nerve defects treated with acellular nerve grafts had positive reflexes already after 2 months. This discrepancy in sensory response could be attributed to the larger nerve gap of 13 mm in our study. The positive reflex appears to be evident earlier than the onset of detectable motor activity. This might suggest that sensory neurons are quicker to regenerate than motor neurons. Furthermore, because neural growth factor primarily improves motor neurons, the regeneration of sensory neurons implies that hascs may have expressed other neurotrophins such as neurotrophin 3 and extracellular matrix molecules. 21 The hascs offer significant advantages over other stem cell types. They are readily accessible, avoid the risks of obtaining neural stem cells directly from the brain, and do not have the pain and complications of obtaining BMSCs through bone marrow aspirations. The hascs can be expanded in culture for many passages in vitro without cell senescence, making immortalization unnecessary. This study demonstrates successful results with respect to direct and indirect functional assessment of the nerve. Despite having to withdraw our hypothesis that hascs would differentiate into neural cells, this study proposes that regeneration may happen through neurotrophin production. Furthermore, because renewing the medium appears to improve parameters of nerve regeneration, it is believed that the differentiation medium plays an important role in nerve healing. Altogether, our peripheral nerve construct strongly promotes nerve regeneration and appears to be comparable with the current gold standard of autograft transplantation. More research is needed to find out whether these hascs express neurotrophins, whether the DE-1 medium is able to induce expression of these factors, and whether these factors are in fact driving the regeneration process. Further studies need to observe the bioactivity changes to determine which factors promote regeneration, find optimal routes of medium renewal, and analyze this system within porous and biodegradable nerve conduits. Accepted for Publication: April 15, 21. Correspondence: Thomas Scholz, MD, Aesthetic and Plastic Surgery Institute, University of California, Irvine, 2 S Manchester Ave, Ste 65, Orange, CA (tscholz@uci.edu). Author Contributions: Study concept and design: Scholz. Acquisition of data: Scholz and Krichevsky. Analysis and interpretation of data: Scholz, Sumarto, and Evans. Drafting of the manuscript: Scholz and Sumarto. Critical revision of the manuscript for important intellectual content: Scholz, Krichevsky, and Evans. Statistical analysis: Scholz. Administrative, technical, and material support: Scholz and Krichevsky. Study supervision: Scholz and Evans. Financial Disclosure: None reported. Previous Presentation: This paper was presented at the 81st Annual Meeting of the Pacific Coast Surgical Association; February 13, 21; Maui, Hawaii. REFERENCES 1. Chalfoun CT, Wirth GA, Evans GR. Tissue engineered nerve constructs: where do we stand? J Cell Mol Med. 26;1(2): Noble J, Munro CA, Prasad VS, Midha R. Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J Trauma. 1998;45(1): Doolabh VB, Hertl MC, Mackinnon SE. The role of conduits in nerve repair: a review. Rev Neurosci. 1996;7(1): Schmidt CE, Leach JB. Neural tissue engineering: strategies for repair and regeneration. Annu Rev Biomed Eng. 23;5: Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA. 1997;94(8): Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279(5356): Krause DS. Plasticity of marrow-derived stem cells. Gene Ther. 22;9(11): Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res. 22; 91(12): Poulsom R, Forbes SJ, Hodivala-Dilke K, et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol. 21;195(2): Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2;61(4): Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 22;13(12): Ashjian PH, Elbarbary AS, Edmonds B, et al. In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg. 23; 111(6): Dhar S, Yoon ES, Kachgal S, Evans GR. Long-term maintenance of neuronally differentiated human adipose tissue-derived stem cells. Tissue Eng. 27;13 (11): Varejão AS, Melo-Pinto P, Meek MF, Filipe VM, Bulas-Cruz J. Methods for the experimental functional assessment of rat sciatic nerve regeneration. Neurol Res. 24;26(2): McConnell MP, Dhar S, Naran S, Nguyen T, Bradshaw RA, Evans GR. In vivo induction and delivery of nerve growth factor, using HEK-293 cells. Tissue Eng. 24;1(9-1): Mackinnon SE, Dellon AL, O Brien JP. Changes in nerve fiber numbers distal to a nerve repair in the rat sciatic nerve model. Muscle Nerve. 1991;14(11): Nie X, Zhang YJ, Tian WD, et al. Improvement of peripheral nerve regeneration by a tissue-engineered nerve filled with ectomesenchymal stem cells. Int J Oral Maxillofac Surg. 27;36(1): Chen CJ, Ou YC, Liao SL, et al. Transplantation of bone marrow stromal cells for peripheral nerve repair. Exp Neurol. 27;24(1): Kim BS, Yoo JJ, Atala A. Peripheral nerve regeneration using acellular nerve grafts. J Biomed Mater Res A. 24;68(2): Clavijo-Alvarez JA, Nguyen VT, Santiago LY, Doctor JS, Lee WP, Marra KG. Comparison of biodegradable conduits within aged rat sciatic nerve defects. Plast Reconstr Surg. 27;119(6): Hari A, Djohar B, Skutella T, Montazeri S. Neurotrophins and extracellular matrix molecules modulate sensory axon outgrowth. Int J Dev Neurosci. 24; 22(2): ARCH SURG/ VOL 146 (NO. 6), JUNE

Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords

Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords Dr. Vasiliki E Kalodimou, Head of Flow Cytometry-Research and Regenerative Medicine Department, IASO-Maternity

More information

InVivo Therapeutics. Developing Innovative Products for Spinal Cord Injury

InVivo Therapeutics. Developing Innovative Products for Spinal Cord Injury 1 Developing Innovative Products for Spinal Cord Injury 2 Forward-Looking Statements Before we begin, we would like to remind everyone that during our presentation, we will be making forward-looking statements

More information

Regeneration of spinal cord injury (SCI) : What we know so far. By: Kendra Michaud

Regeneration of spinal cord injury (SCI) : What we know so far. By: Kendra Michaud Regeneration of spinal cord injury (SCI) : What we know so far By: Kendra Michaud INTRODUCTION BACKGROUND/IMPACT Neerumalla, Dr. Ravali. Spinal Cord Injury - Causes, Symptoms, Diagnosis, Treatment & Prevention.

More information

Des cellules-souches dans le poumon : pourquoi faire?

Des cellules-souches dans le poumon : pourquoi faire? Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland

More information

Stem cells and motor neurone disease

Stem cells and motor neurone disease Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and includes details of the current

More information

At the conclusion of this lesson you should be able to:

At the conclusion of this lesson you should be able to: Learning Objectives At the conclusion of this lesson you should be able to: Understand the key terms and definitions regarding stem cells Differentiate between the adult and embryonic stem cells Differentiate

More information

Introduction to Cell- Biomaterial Engineering!

Introduction to Cell- Biomaterial Engineering! Introduction to Cell- Biomaterial Engineering! Module 3, Lecture 1! 20.109 Spring 2010! Topics for Lecture 1!! Introduction to tissue engineerin! motivation"! basic principles + examples"! Introduction

More information

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017 The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017 Cell Therapy and Parkinson s Disease Very specific neural degeneration >50% of DA neurons are gone by diagnosis 1 million in the USA,

More information

Discover TruPRP. PRP the way you want it.

Discover TruPRP. PRP the way you want it. Discover TruPRP PRP the way you want it. Discover TruPRP Discover the quality of Magellan TruPRP. The Magellan technology provides an automated dual spin processing system that can deliver (PRP) Platelet

More information

In vitro Human Umbilical Vein Endothelial Cells (HUVEC) Tube-formation Assay. Josephine MY Ko and Maria Li Lung *

In vitro Human Umbilical Vein Endothelial Cells (HUVEC) Tube-formation Assay. Josephine MY Ko and Maria Li Lung * In vitro Human Umbilical Vein Endothelial Cells (HUVEC) Tube-formation Assay Josephine MY Ko and Maria Li Lung * Clinical Oncology Department, The Univerisity of Hong Kong, Hong Kong, Hong Kong SAR *For

More information

Clip 1: Hip dysplasia Clip 2: Vet-Stem s Dr. Harman

Clip 1: Hip dysplasia Clip 2: Vet-Stem s Dr. Harman Stem Cells Many breeds of large dogs are affected by hip dysplasia. This degenerative disease affects their hind legs, hindering mobility. Watch as scientists at Vet-Stem explain how stem cells are used

More information

Department of Metallurgy and Materials Engineering, Katholieke Universiteit Leuven, B Leuven, Belgium; 2

Department of Metallurgy and Materials Engineering, Katholieke Universiteit Leuven, B Leuven, Belgium; 2 Micro-CT: a powerful tool for the characterization and evaluation of the bone formatting capacity of calcium phosphate stem cells tissue engineering constructs G. Kerckhofs 1,2, SJ. Roberts 2,3, M. Wevers

More information

NEURONAL CELL CULTURE MATRIX FOR BETTER MAINTENANCE AND SURVIVAL OF NEURONAL CELL CULTURES IN TISSUE CULTURE.

NEURONAL CELL CULTURE MATRIX FOR BETTER MAINTENANCE AND SURVIVAL OF NEURONAL CELL CULTURES IN TISSUE CULTURE. NEURONAL CELL CULTURE MATRIX FOR BETTER MAINTENANCE AND SURVIVAL OF NEURONAL CELL CULTURES IN TISSUE CULTURE. D. R. Aguirre, N. DiMassa, Chrystal Johnson, H. Eran, R. Perez, C.V.R. Sharma, M.V.R. Sharma,

More information

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY: NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY: Potent biological scaffolds strategically control stem cell fate and function, allowing our allografts to harness the regenerative potential of patient s

More information

PTH Effects Bone Healing and Vasculogenesis in Calvaria Bone Allograft Model

PTH Effects Bone Healing and Vasculogenesis in Calvaria Bone Allograft Model PTH Effects Bone Healing and Vasculogenesis in Calvaria Bone Allograft Model Dmitriy Sheyn, PhD 1, Doron Cohn-Yakubovich, BSc 2, Ilan Kallai, MSc 2, Susan Su, MD 1, Xiaoyu Da, MSc 1, Gadi Pelled, DMD,

More information

Functional Assessment and Clinical Outcome

Functional Assessment and Clinical Outcome Tissue Engineering Functional Assessment and Clinical Outcome STEVEN A. GOLDSTEIN Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan 48109,

More information

Future implications of regenerative medicine on assisted reproductive technology. Regenerative medicine. History of Regenerative medicine

Future implications of regenerative medicine on assisted reproductive technology. Regenerative medicine. History of Regenerative medicine Gyndolomiti: 2nd Congress on Gynaecology and Obstetrics February 1 6, 2015 St. Kassian / South Tyrol Regenerative medicine Future implications of regenerative medicine on assisted reproductive technology

More information

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications Xeno-Free Systems for hesc & hipsc Facilitating the shift from Stem Cell Research to Clinical Applications NutriStem Defined, xeno-free (XF), serum-free media (SFM) specially formulated for growth and

More information

LHCN-M2 cell culture, differentiation treatment, and cross-linking protocol.

LHCN-M2 cell culture, differentiation treatment, and cross-linking protocol. Cell Growth Protocol and Differentiation treatment for the LHCN-M2 Cell Line From: HudsonAlpha/Caltech ENCODE group Date: February 17, 2011 Prepared by: Chun-Hong Zhu and Woodring E. Wright (typed by Brian

More information

Propagation of H7 hesc From: UW (John Stamatoyannopoulos) ENCODE group Date: 12/17/2009 Prepared By: S. Paige/S. Hansen (UW)

Propagation of H7 hesc From: UW (John Stamatoyannopoulos) ENCODE group Date: 12/17/2009 Prepared By: S. Paige/S. Hansen (UW) Propagation of H7 hesc From: UW (John Stamatoyannopoulos) ENCODE group Date: 12/17/2009 Prepared By: S. Paige/S. Hansen (UW) Growth and Harvest Modifications Addendum to: Propagation of H7 hesc from UW

More information

Osteogenic Differentiation and Analysis of MSC

Osteogenic Differentiation and Analysis of MSC Osteogenic Differentiation and Analysis of MSC Application Note Background Mesenchymal Stem Cells (MSC) are fibroblastoid multipotent adult stem cells with a high capacity for self-renewal. So far, these

More information

Patient Handbook on Stem Cell Therapies

Patient Handbook on Stem Cell Therapies Patient Handbook on Stem Cell Therapies WWW.ISSCR.ORG WWW.CLOSERLOOKATSTEMCELLS.ORG Patient Handbook on Stem Cell Therapies Introduction We have all heard about the extraordinary promise that stem cell

More information

WHITE PAPER: ATELO COLLAGEN. Product Number: FS22001, FS22002, FS22003, FS22004, FS22005, FS22006

WHITE PAPER: ATELO COLLAGEN. Product Number: FS22001, FS22002, FS22003, FS22004, FS22005, FS22006 Page 1 of 5 WHITE PAPER: ATELO COLLAGEN 1.0 GENERAL INFORMATION Material Name: Pepsin Soluble Atelo Collagen in 0.01M HCl Product Number: FS22001, FS22002, FS22003, FS22004, FS22005, FS22006 Product Description/

More information

ReproRNA -OKSGM is a non-integrating, self-replicating RNA-based reprogramming vector for generating induced pluripotent stem (ips)

ReproRNA -OKSGM is a non-integrating, self-replicating RNA-based reprogramming vector for generating induced pluripotent stem (ips) Kit for generating ips cells using ReproRNA -OKSGM, a non-integrating, self-replicating RNA reprogramming vector Product Description ReproRNA -OKSGM is a non-integrating, self-replicating RNA-based reprogramming

More information

EPC Derivation from Whole Blood

EPC Derivation from Whole Blood Page 1 Overview This protocol describes procedures for isolation and expansion of human blood-outgrowth endothelial progenitor cells (EPCs) from human blood using a Ficoll gradient separation to isolate

More information

Enzyme-mediated preparation of hydrogels composed of poly(ethylene glycol) and gelatin as cell culture platforms

Enzyme-mediated preparation of hydrogels composed of poly(ethylene glycol) and gelatin as cell culture platforms Electronic Supplementary Material (ESI) for RSC Advances. This journal is The Royal Society of Chemistry 2014 Supplementary Material (ESI) for RSC Advances Enzyme-mediated preparation of hydrogels composed

More information

Stem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean?

Stem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean? STO-120 Stem Cells Part 1: What is a Stem Cell? Stem cells differ from other kinds of cells in the body. When a stem cell divides by mitosis, each new cell has the potential to either remain a stem cell

More information

hpsc Maintenance Media

hpsc Maintenance Media hpsc Maintenance Media Brigitte Arduini, version 2, 2013-Jun-12 Initially, it was found that pluripotency of human pluripotent stem cells (hpscs) can be maintained when plated in co-culture with mouse

More information

BD MOSAIC h MSC CELL CULTURE ENVIRONMENT DEFINED SERUM FREE

BD MOSAIC h MSC CELL CULTURE ENVIRONMENT DEFINED SERUM FREE BD MOSAIC h MSC CELL CULTURE ENVIRONMENT DEFINED SERUM FREE As the promise of stem cell therapy grows, so does the need for reliable tools for cell expansion in both research and clinical applications.

More information

Agilent Seahorse XF Live-Cell Metabolism Solutions for STEM CELL RESEARCH

Agilent Seahorse XF Live-Cell Metabolism Solutions for STEM CELL RESEARCH Agilent Seahorse XF Live-Cell Metabolism Solutions for STEM CELL RESEARCH MONITOR CELL FATE TRANSITIONS Improve Differentiation and Reprogramming Outcomes Adult Fibroblast Cells Reprogramming (ips Cells)

More information

Catalog # Product Size PRIME-XV Hematopoietic Cell Basal XSFM 500 ml (liquid) Additional package sizes are available at request

Catalog # Product Size PRIME-XV Hematopoietic Cell Basal XSFM 500 ml (liquid) Additional package sizes are available at request PRIME-XV HEMATOPOIETIC CELL BASAL XSFM PRIME-XV Hematopoietic Cell Basal XSFM is an optimized xeno- and serum free media recommended for use in the expansion of human hematopoietic cells, including hematopoietic

More information

The Hollow Fiber Bioreactor and Cell Co-Cultivation

The Hollow Fiber Bioreactor and Cell Co-Cultivation The Hollow Fiber Bioreactor and Cell Co-Cultivation June 12, 2012 John J.S. Cadwell Historically, the scientific method had been based upon the reduction of complex systems to their simplest forms in order

More information

Stem Cells 101. Christopher Centeno, M.D. The Centeno-Schultz Clinic Colorado, USA

Stem Cells 101. Christopher Centeno, M.D. The Centeno-Schultz Clinic Colorado, USA Stem Cells 101 Christopher Centeno, M.D. The Centeno-Schultz Clinic Colorado, USA My background Began using stem cells to treat orthopedic conditions in 2005 Have published 16 peer reviewed publications

More information

Blue Marble University Biology Course Handbook

Blue Marble University Biology Course Handbook Blue Marble University Biology Course Handbook A Summary of Course Descriptions Courses and Content Subject to Change Without Notice BlueMarbleUniversity.com Info@bluemarbleuniversity.com Stem Cell Biology

More information

Supplemental Information Inventory

Supplemental Information Inventory Cell Stem Cell, Volume 6 Supplemental Information Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by TGF-β1 Grant A. Challen, Nathan C. Boles, Stuart M. Chambers, and Margaret A.

More information

Embryonic development, epigenics and somatic cell nuclear transfer - The science and its social implications -

Embryonic development, epigenics and somatic cell nuclear transfer - The science and its social implications - Embryonic development, epigenics and somatic cell nuclear transfer - The science and its social implications - Moshe Yaniv Unité d Expression Génétique et Maladies, Institut Pasteur, Paris, France September

More information

Facts and theories of organ regeneration in adults

Facts and theories of organ regeneration in adults Harvard-MIT Division of Health Sciences and Technology HST.535: Principles and Practice of Tissue Engineering Instructor: I. V. Yannas Facts and theories of organ regeneration in adults I.V.Yannas, PhD

More information

Amaxa Basic Neuron SCN Nucleofector Kit

Amaxa Basic Neuron SCN Nucleofector Kit Amaxa Basic Neuron SCN Nucleofector Kit For Primary Neural Cells (Small Cell Number) SCN Nucleofector Kits are compatible with Nucleofector ll Devices of serial version S with software version S4 4 or

More information

Immunogenicity of Stem Cells in Therapeutic Applications. MDPB-Registry meeting nov 25th Stem cell immunogenicity in therapeutic applications

Immunogenicity of Stem Cells in Therapeutic Applications. MDPB-Registry meeting nov 25th Stem cell immunogenicity in therapeutic applications Immunogenicity of Stem Cells in Therapeutic Applications MDPB-Registry meeting nov 25th 2016 Stem cell immunogenicity in therapeutic applications Has it been underestimated? Transplantation of any type

More information

Copyright Warning & Restrictions

Copyright Warning & Restrictions Copyright Warning & Restrictions The copyright law of the United States (Title 17, United States Code) governs the making of photocopies or other reproductions of copyrighted material. Under certain conditions

More information

STEM CELLS. An Interactive Qualifying Project Report. Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE

STEM CELLS. An Interactive Qualifying Project Report. Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE IQP-43-DSA-2135 IQP-43-DSA-8130 STEM CELLS An Interactive Qualifying Project Report Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE In partial fulfillment of the requirements for the Degree

More information

Use of Phase Contrast Imaging to Track Morphological Cellular Changes due to Apoptotic Activity

Use of Phase Contrast Imaging to Track Morphological Cellular Changes due to Apoptotic Activity A p p l i c a t i o n N o t e Use of Phase Contrast Imaging to Track Morphological Cellular Changes due to Apoptotic Activity Brad Larson and Peter Banks, Applications Department, BioTek Instruments, Inc.,

More information

NTM486-04, NTM174-04,

NTM486-04, NTM174-04, Transfection of transformed human trabecular meshwork TM5, and primary human NTM210-05, NTM486-04, NTM174-04, and NTM153-00 cells with Metafectene Easy Adnan Dibas1A,C, Ming Jiang1A,C, Thomas Yorio1A,C.

More information

Efficient Expansion of Human Mesenchymal Stem Cells (hmscs) on Corning Enhanced Attachment Microcarriers Using a Continuous Agitation Protocol

Efficient Expansion of Human Mesenchymal Stem Cells (hmscs) on Corning Enhanced Attachment Microcarriers Using a Continuous Agitation Protocol Efficient Expansion of Human Mesenchymal Stem Cells (hmscs) on Corning Enhanced Attachment Microcarriers Using a Continuous Agitation Protocol Application Note Jennifer L. Weber, Lori E. Romeo, and Jennifer

More information

Creating RAFT 3D Cell Cultures with Different Thicknesses and Different Cell Types

Creating RAFT 3D Cell Cultures with Different Thicknesses and Different Cell Types Bioscience Solutions Creating RAFT 3D Cell s with Different Thicknesses and Different Cell Types Sabine Schaepermeier 1, Lubna Hussain 2, Jenny Schroeder 1 1 Lonza Cologne GmbH, Cologne, Germany; 2 Lonza

More information

In vivo BrdU Incorporation Assay for Murine Hematopioetic Stem Cells Ningfei An, Yubin Kang *

In vivo BrdU Incorporation Assay for Murine Hematopioetic Stem Cells Ningfei An, Yubin Kang * In vivo BrdU Incorporation Assay for Murine Hematopioetic Stem Cells Ningfei An, Yubin Kang * Division of Hematology-Oncology, Department of Medicine, Medical University of South Carolina, Charleston,

More information

Transfection of Mouse ES Cells and Mouse ips cells using the Stemfect 2.0 -mesc Transfection Reagent

Transfection of Mouse ES Cells and Mouse ips cells using the Stemfect 2.0 -mesc Transfection Reagent APPLICATION NOTE Page 1 Transfection of Mouse ES Cells and Mouse ips cells using the Stemfect 2.0 -mesc Transfection Reagent Authors: Amelia L. Cianci 1, Xun Cheng 1 and Kerry P. Mahon 1,2 1 Stemgent Inc.,

More information

T ECHNICAL MANUAL. Culture of Human Mesenchymal Stem Cells Using MesenCult -XF Medium

T ECHNICAL MANUAL. Culture of Human Mesenchymal Stem Cells Using MesenCult -XF Medium T ECHNICAL MANUAL Culture of Human Mesenchymal Stem Cells Using MesenCult -XF Medium i Table of Contents 1.0 Materials... 1 1.1 MesenCult -XF Medium and Required Products... 1 1.2 Additional Required

More information

Formation of Mesenchymal Tissues in Alvetex Scaffold Derived From Stem Cells and Established Cell Lines. Introduction

Formation of Mesenchymal Tissues in Alvetex Scaffold Derived From Stem Cells and Established Cell Lines. Introduction Formation of Mesenchymal Tissues in Derived From Stem Cells and Established Cell Lines Application Note 1 Highlights: Sustained long-term culture of un rat MSCs in Enhanced expression of osteogenic and

More information

Protocols for Hematopoietic Differentiation of Murine ES Cells (in 6 or 24 well plates) Media Preparation

Protocols for Hematopoietic Differentiation of Murine ES Cells (in 6 or 24 well plates) Media Preparation Protocols for Hematopoietic Differentiation of Murine ES Cells (in 6 or 24 well plates) Media Preparation A) Embryonic Stem Cell Medium (ES) Dulbecco s modified Eagle s Medium (DMEM) with high glucose

More information

From Stem Cell to Any Cell

From Stem Cell to Any Cell sciencenewsforkids.org http://www.sciencenewsforkids.org/2005/10/from-stem-cell-to-any-cell-2/ From Stem Cell to Any Cell By Emily Sohn / October 11, 2005 For maybe a day, about 9 months before you were

More information

STEM CELLS IN NEUROLOGY ISABELLE COCHRANE MERIT

STEM CELLS IN NEUROLOGY ISABELLE COCHRANE MERIT STEM CELLS IN NEUROLOGY BY ISABELLE COCHRANE MERIT RESEARCH PAPER BASED ON PATHOLOGY LECTURES AT MEDLINK 2011 1 Abstract Ever since their discovery, stem cells have been heralded as the ultimate cure to

More information

Stem Cells: The Revolution of Blood Transfusion. By Srinand Sundaram. Grade awarded: Pass with Merit

Stem Cells: The Revolution of Blood Transfusion. By Srinand Sundaram. Grade awarded: Pass with Merit Stem Cells: The Revolution of Blood Transfusion By Srinand Sundaram Grade awarded: Pass with Merit Research Paper Based on Pathology Lectures At Medlink, December 2014 Abstract For people around the world

More information

SKIN INFECTION OF RABBITS WITH HEMOLYTIC STREP- TOCOCCI ISOLATED FROM A PATIENT WITH ERYSIPELAS.

SKIN INFECTION OF RABBITS WITH HEMOLYTIC STREP- TOCOCCI ISOLATED FROM A PATIENT WITH ERYSIPELAS. SKIN INFECTION OF RABBITS WITH HEMOLYTIC STREP- TOCOCCI ISOLATED FROM A PATIENT WITH ERYSIPELAS. I. METHOD OF DEMONSTRATING PROTECTIVE ACTION OF IMMUNE SERA. BY THOMAS M. RIVERS, M.D. (From the Hospital

More information

Test report and professional information. Mini-Rayonex

Test report and professional information. Mini-Rayonex 1 (5) Dartsch Scientific GmbH! Oskar-von-Miller-Str. 10! D-86956 Schongau Firma Rayonex Biomedical GmbH c/o Prof. Dietmar Heimes Sauerland-Pyramiden 1 D-57368 Lennestadt Oskar-von-Miller-Straße 10 D-86956

More information

Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. JournalClub Emilie Hrdliczka

Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. JournalClub Emilie Hrdliczka Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration JournalClub 14.12.2015 Emilie Hrdliczka Facts Author: Yongyou Zhang Department of Medicine, Case Western Reserve

More information

Human Stellate Cell Care Manual

Human Stellate Cell Care Manual Human Stellate Cell Care Manual INSTRUCTION MANUAL SHIPPING CONDITIONS Human Stellate Cells, cryopreserved ZBM0069.06 Orders are delivered via Federal Express courier. All US and Canada orders are shipped

More information

Adult Stem Cells by David A. Prentice, Ph.D.

Adult Stem Cells by David A. Prentice, Ph.D. Adult Stem Cells by David A. Prentice, Ph.D. Within just a few years, the possibility that the human body contains cells that can repair and regenerate damaged and diseased tissue has gone from an unlikely

More information

Lab Module 7: Cell Adhesion

Lab Module 7: Cell Adhesion Lab Module 7: Cell Adhesion Tissues are made of cells and materials secreted by cells that occupy the spaces between the individual cells. This material outside of cells is called the Extracellular Matrix

More information

The use of VEGF supplemented media for chondrogenic differentiation of adipose derived mesenchymal stem cells

The use of VEGF supplemented media for chondrogenic differentiation of adipose derived mesenchymal stem cells ISSN : 0974-7435 Volume 7 Issue 5 BTAIJ, 7(5), 2013 [169-173] The use of VEGF supplemented media for chondrogenic differentiation of adipose derived mesenchymal stem cells Jeanne Adiwinata Pawitan 1*,

More information

Over the past decade, autologous and allogeneic grafts

Over the past decade, autologous and allogeneic grafts TISSUE ENGINEERING: Part B Volume 22, Number 3, 2016 ª Mary Ann Liebert, Inc. DOI: 10.1089/ten.teb.2015.0290 REVIEW ARTICLE Cell-Derived Extracellular Matrix: Basic Characteristics and Current Applications

More information

Protocol for induction of expression and cell lysate production

Protocol for induction of expression and cell lysate production Protocol for induction of expression and cell lysate production AV-04 Doxycyclin induction and cell lysate 1.0 Introduction / Description This method is intended for the treatment of the previously transfected

More information

Stem Cell Principle -

Stem Cell Principle - Effective Date: 31.10.2017 Doc ID: 20290214 Version: 1.0 Status: Approved Planned Effective Date: 31-Oct-2017 00:00 CET (Server Date) Stem Cell Principle - Rationale Research on human stem cells and their

More information

Frequently Asked Questions Stem Cells

Frequently Asked Questions Stem Cells Q: Do you add antibiotics to your media? A: Coriell does not use antibiotics when culturing stem cells. Customers should be aware that inclusion of antibiotics in media may change growth characteristics

More information

Antibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies

Antibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies Human AB Serum Product Description Human AB Serum is a vital cell culture reagent for some human cell types providing growth factors, vitamins, nutrients as well as trace elements and transport factors,

More information

Mouse Mesenchymal Stem Cell Functional Identification Kit

Mouse Mesenchymal Stem Cell Functional Identification Kit Mouse Mesenchymal Stem Cell Functional Identification Kit Catalog Number SC010 Reagents for the identification of mouse bone marrow-derived stem cells (BMSC)/mesenchymal stem cells (MSC) by in vitro functional

More information

RegenACR. autologous cellular regeneration. RegenACR A-PRP treatment. collagen fibers. 1,2 texture and elasticity. 3 volume & strength.

RegenACR. autologous cellular regeneration. RegenACR A-PRP treatment. collagen fibers. 1,2 texture and elasticity. 3 volume & strength. RegenACR autologous cellular regeneration RegenACR A-PRP treatment collagen fibers. 1,2 texture and elasticity. 3 volume & strength. 4,5 WHAT IS A-PRP Autologous Platelet Rich Plasma Plasma contains many

More information

Award Number: W81XWH TITLE: Magnetic Resonance Characterization of Axonal Response to Spinal Cord Injury

Award Number: W81XWH TITLE: Magnetic Resonance Characterization of Axonal Response to Spinal Cord Injury AD Award Number: W81XWH-10-1-0713 TITLE: Magnetic Resonance Characterization of Axonal Response to Spinal Cord Injury PRINCIPAL INVESTIGATOR: David B Hackney CONTRACTING ORGANIZATION: Beth Israel Deaconess

More information

Using The Context: Level H By Boning

Using The Context: Level H By Boning Using The Context: Level H By Boning If you are looking for the book by Boning Using the Context: Level H in pdf form, in that case you come on to the right site. We furnish full edition of this book in

More information

Data Sheet. Hippo Pathway TEAD Reporter MCF7 Cell Line Catalog #: 60618

Data Sheet. Hippo Pathway TEAD Reporter MCF7 Cell Line Catalog #: 60618 Data Sheet Hippo Pathway TEAD Reporter MCF7 Cell Line Catalog #: 6618 Background The Hippo pathway regulates cell proliferation and cell death. It is activated by high cell density and cell stress to stop

More information

Primary Mouse Embryonic Fibroblast Isolation Kit

Primary Mouse Embryonic Fibroblast Isolation Kit INSTRUCTIONS Primary Mouse Embryonic Fibroblast Isolation Kit 88279 Number Description Pub. No. MAN0016041 Rev A.0 Pub. Part No. 2162551.0 88279 Pierce Mouse Embryonic Fibroblast (MEF) Isolation Kit, contains

More information

Protocols for Neural Progenitor Cell Expansion and Dopaminergic Neuron Differentiation

Protocols for Neural Progenitor Cell Expansion and Dopaminergic Neuron Differentiation Protocols for Neural Progenitor Cell Expansion and Dopaminergic Neuron Differentiation In vitro neurological research presents many challenges due to the difficulty in establishing high-yield neuronal

More information

INVESTIGATION OF MSC DIFFERENTIATION ON ELECTROSPUN NANOFIBROUS SCAFFOLDS

INVESTIGATION OF MSC DIFFERENTIATION ON ELECTROSPUN NANOFIBROUS SCAFFOLDS With support of NSF Award no. EEC-0754741 INVESTIGATION OF MSC DIFFERENTIATION ON ELECTROSPUN NANOFIBROUS SCAFFOLDS NSF Summer Undergraduate Fellowship in Sensor Technologies Emily Wible (Bioengineering)

More information

What Are Stem Cells? Where Are These Stem Cells?

What Are Stem Cells? Where Are These Stem Cells? While stem cell therapies may seem to have appeared overnight, they have been practiced for some time prior to the recent burst in new applications and stem cell sources. The most recent developments in

More information

Project Proposal Ultrasound Mediated Tissue Engineering Project Team 21

Project Proposal Ultrasound Mediated Tissue Engineering Project Team 21 Project Proposal Ultrasound Mediated Tissue Engineering Project Team 21 Nicholas Calistri, Aimon Iftikhar, Yvonne Nanakos and Kelly Stratton Project 40 for Dr. Yusuf Khan University of Connecticut Health

More information

Stem cell transfection guide

Stem cell transfection guide APPLICATION NOTE Stem cell transfection guide Gene delivery solutions Introduction Stem cells continue to show immense promise for the future of regenerative medicine and personalized therapeutic treatments.

More information

Developing a real-time fluorescence cell growth monitoring system

Developing a real-time fluorescence cell growth monitoring system - 65 - Developing a real-time fluorescence cell growth monitoring system Jo-Ting Wang 1, Chun-Han Lu 2, Yao-Nan Wang 2, Ko-Tung Chang 1,* 1 Department of Biological Science and Technology, National Pingtung

More information

TECHNICAL BULLETIN NUCLEI EZ PREP NUCLEI ISOLATION KIT. Product Number NUC-101 Store at 2-8 C

TECHNICAL BULLETIN NUCLEI EZ PREP NUCLEI ISOLATION KIT. Product Number NUC-101 Store at 2-8 C NUCLEI EZ PREP NUCLEI ISOLATION KIT Product Number NUC-101 Store at 2-8 C TECHNICAL BULLETIN Product Description Sigma s Nuclei EZ Prep Kit is designed for the rapid isolation of nuclei from mammalian

More information

Smooth Muscle-Specific Expression of ipla 2 β Participates in the Initiation and Early Progression of Vascular Inflammation and Neointima Formation

Smooth Muscle-Specific Expression of ipla 2 β Participates in the Initiation and Early Progression of Vascular Inflammation and Neointima Formation Smooth Muscle-Specific Expression of ipla 2 β Participates in the Initiation and Early Progression of Vascular Inflammation and Neointima Formation Shu Liu 1, Zhongwen Xie 2, Qingwei Zhao 2, Huan Pang

More information

5.5. Multicellular Life. Multicellular organisms depend on interactions among different cell types.

5.5. Multicellular Life. Multicellular organisms depend on interactions among different cell types. 5.5 Multicellular Life VOCABULARY tissue organ organ system cell differentiation stem cell Key Concept Cells work together to carry out complex functions. MAIN IDEAS Multicellular organisms depend on interactions

More information

Human Pluripotent Stem Cell Functional Identification Kit

Human Pluripotent Stem Cell Functional Identification Kit Human Pluripotent Stem Cell Functional Identification Kit Catalog Number SC027B Reagents for the identification of human pluripotent stem cells by in vitro functional differentiation. This package insert

More information

Comparison of Flowcytometric and Immunocytochemistry Analysis of Stem Cell Surface Markers

Comparison of Flowcytometric and Immunocytochemistry Analysis of Stem Cell Surface Markers OnLine Journal of Biological Sciences Original Research Paper Comparison of Flowcytometric and Immunocytochemistry Analysis of Stem Cell Surface Markers 1,2 Jeanne Adiwinata Pawitan, 3 Dewi Wulandari,

More information

Generation of Mouse Spinal Cord Injury Oneil G. Bhalala *, Liuliu Pan, Hilary North, Tammy McGuire and John A. Kessler

Generation of Mouse Spinal Cord Injury Oneil G. Bhalala *, Liuliu Pan, Hilary North, Tammy McGuire and John A. Kessler Generation of Mouse Spinal Cord Injury Oneil G. Bhalala *, Liuliu Pan, Hilary North, Tammy McGuire and John A. Kessler Department of Neurology, Northwestern University, Chicago, USA *For correspondence:

More information

64 CuCl 2 in 50 µl 0.1N NaOAc buffer, and 20 µg of each DOTA-antibody conjugate in 40 µl

64 CuCl 2 in 50 µl 0.1N NaOAc buffer, and 20 µg of each DOTA-antibody conjugate in 40 µl Number of DOTA per antibody The average number of DOTA chelators per antibody was measured using a reported procedure with modifications (1,2). Briefly, nonradioactive CuCl 2 (80-fold excess of DOTA antibodies)

More information